Legend Biotech (LEGN)

• Market cap: $5.24B
• 1 day: -1.1%
• 5 days: -9.16%
• 1 month: -22.32%
• 3 months: 49.12%
• 6 months: 14.26%
• Year to date: 25.89%
• 1 year: -31.81%
• 5 years: -31.98%
• 10 years: -26.81%
• Sector: Healthcare
• Industry: Biotechnology

About: Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Employees: 2,900